KU812 basophils express urocortin, CRH-R, MC1R and steroidogenic enzymes and secrete progesterone

Experimental Dermatology

Volumn 21, Issue 7, 2012, Pages 541-543

  Böhm, Markus ^a   Zmijewski, Michal A ^b,c   Wasiewicz, Tomasz ^c   Straub, Rainer H ^d   Raap, Ulrike ^e   Luger, Thomas A ^a   Slominski, Andrzej ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c MEDICAL UNIVERSITY OF GDANSK   (Poland)

^d UNIVERSITY OF REGENSBURG   (Germany)

^e HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Basophils; Hypothalamic pituitary adrenal axis; Neurohormones; Neuropeptides; Steroid hormones

Indexed keywords

CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; CYP21A2; CYTOCHROME; CYTOCHROME P450 17; MELANOCORTIN; NEUROPEPTIDE; PROGESTERONE; UNCLASSIFIED DRUG; UROCORTIN I; UROCORTIN II; UROCORTIN III;

CELL LINE; HORMONE RELEASE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IN VITRO STUDY; KU812 BASOPHIL; LETTER; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEROIDOGENESIS;

BASOPHILS; CELLS, CULTURED; CHOLESTEROL SIDE-CHAIN CLEAVAGE ENZYME; CORTICOTROPIN-RELEASING HORMONE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; PITUITARY-ADRENAL SYSTEM; PRO-OPIOMELANOCORTIN; PROGESTERONE; RECEPTOR, MELANOCORTIN, TYPE 1; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; STEROID 17-ALPHA-HYDROXYLASE; STEROID 21-HYDROXYLASE; UROCORTINS;

EID: 84863108667     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2012.01513.x     Document Type: Letter

References (28)

1. Schroeder J T. Immunol Rev 2011: 242: 144-160.
2. Falcone F H, Knol E F, Gibbs B F. Clin Exp Allergy 2011: 41: 939-947.
3. Macfarlane A J, Kon O M, Smith S J et al. J Allergy Clin Immunol 2000: 105: 99-107.
4. Iliopoulos O, Baroody F M, Naclerio R M et al. J Immunol 1992: 148: 2223-2228.
5. Irani A M, Huang C, Xia H Z et al. J Allergy Clin Immunol 1998: 101: 354-362.
6. Slominski A, Mihm M C. Int J Dermatol 1996: 35: 849-851.
7. Slominski A, Wortsman J, Luger T et al. Physiol Rev 2000: 80: 979-1020.
8. Marshall G D. Ann Allergy Asthma Immunol 2004: 93: S11-S17.
9. Wrona D. J Neuroimmunol 2006: 172: 38-58.
10. Catania A. J Leukoc Biol 2007: 81: 383-392.
11. Kishi K. Leuk Res 1985: 9: 381.
12. Slominski A, Ermak G, Hwang J et al. FEBS Lett 1995: 374: 113-116.
13. Zmijewski M A, Sharma R K, Slominski A T. J Endocrinol 2007: 193: 157-169.
14. Slominski A, Roloff B, Curry J et al. J Clin Endocrinol Metab 2000: 85: 815-823.
15. Slominski A, Pisarchik A, Tobin D J et al. Endocrinology 2004: 145: 941-950.
16. Pisarchik A, Slominski A T. FASEB Journal 2001: 15: 2754-2756.
17. Böhm M, Raghunath M, Sunderkötter C et al. J Biol Chem 2004: 279: 6959-6966.
18. Slominski A, Zjawiony J, Wortsman J et al. Europ J Biochem 2004: 271: 4178-4188.
19. Böhm M, Schulte U, Schiller M et al. Ann NY Acad Sci 1999: 885: 372-382.
20. Böhm M, Metze D, Schulte U et al. Exp Dermatol 1999: 8: 453-461.
21. Phillips C, Coward W R, Pritchard D I et al. J Leukoc Biol 2003: 73: 165-171.
22. Higa S, Hirano T, Kotani M et al. J Allergy Clin Immunol 2003: 111: 1299-1306.
23. Slominski A, Wortsman J, Tuckey R C et al. Mol Cell Endocrinol 2007: 265-266: 143-149.
24. Böhm M, Apel M, Sugawara K et al. J Allergy Clin Immunol 2012: 129: 1085-1093.
25. Singh L K, Boucher W, Pang X et al. J Pharmacol Exp Ther 1999: 288: 1349-1356.
26. Kempuraj D, Papadopoulou N G, Lytinas M et al. Endocrinology 2004: 145: 43-48.
27. Miyaura H, Iwata M. J Immunol. 2002: 168: 1087-1094.
28. Rozniecki J J, Dimitriadou V, Lambracht-Hall M et al. Brain Res 1999: 849: 1-15.